The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further RIF-loaded SLNs have been found to be suitable for AM targeted delivery due to the specific internalization of nanosized SLNs into AM.218”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [218]
In the citing paper
“pulmonary administration of rifampicin-loaded solid lipid nanoparticles in rats enabled delivery to alveolar macrophages 131 .”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [131]
Citations
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,958
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,286
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
McKinney, J. D., zu Bentrup, K. H., Muñoz‐Elías, E. J., Miczák, A., Chen, B., Chan, W.-T., Swenson, D. L., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,361
Armstrong, J. A., & Hart, P. D. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.713 · Cited by 991
A Coat Protein on Phagosomes Involved in the Intracellular Survival of Mycobacteria
Ferrari, G., Langen, H., Naito, M., & Pieters, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80754-0 · Cited by 586
CELL BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS PHAGOSOME
Vergne, I., Chua, J., Singh, S., & Deretic, V. P. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.114015 · Cited by 440
Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271
Cited by
Sorted by citations
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Nanotechnology approaches for global infectious diseases
Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Paranjpe, M., & Müller-Goymann, C. C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045852 · Cited by 467
Doktorovová, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery
Liu, Q., Guan, J., Lu, Q., Zhang, X., & Mao, S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.023 · Cited by 239
Metadata
- Authors
- Chuan, J., Li, Y., Yang, L., Sun, X., Zhang, Q., Gong, T., & Zhang, Z.
- Affiliations
- Sichuan University (CN)
- Tianjin Institute of Pharmaceutical Research (China) (CN)
- Peking University (CN)
- Corresponding author
- Gong, Tao
- Zhang, Zhirong
- Venue
- Journal of Nanoparticle Research
- Published
- 2013-04-11
- Volume
- 15
- Issue
- 5
- ISSN
- 1388-0764 (ISSN-L)
- 1572-896X
- OpenAlex
- W2016812928
- Cited by
- 107
- References
- 37
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 11 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 11 · 2013: 1
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Nanoparticle Research (publishedVersion)
- Funders
- International Society of Travel Medicine
- National Key Research and Development Program of China
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- rifampicin, solid lipid nanoparticles, alveolar macrophages, tuberculosis, targeted drug delivery, alveolar type II cells, nanoparticle uptake, pulmonary administration, lipid film hydration, cytotoxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
